Summary

The global market for Blockchain In Pharmaceutical was estimated to be worth US$ 4667 million in 2024 and is forecast to a readjusted size of US$ 96750 million by 2031 with a CAGR of 55.0% during the forecast period 2025-2031.
Blockchain In Pharmaceutical refers to the application of blockchain technology in the healthcare field. It allows personal health information to be stored in the network, enabling healthcare providers to have broader access to patients' basic health information while securely storing this information through encrypted signatures.
Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91%. For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69%.
Market Drivers
1. Supply Chain Transparency and Traceability
Blockchain provides an immutable and decentralized ledger that enables end-to-end visibility across the pharmaceutical supply chain. This helps combat counterfeit drugs, track the movement of raw materials and finished products, and ensure authenticity, which is critical for patient safety.
2. Counterfeit Drug Prevention
Counterfeit drugs pose a significant threat to global health, costing the industry billions annually. Blockchain’s ability to create tamper-proof records ensures that every drug can be traced back to its origin, reducing the risk of counterfeit products entering the market.
3. Regulatory Compliance
Pharmaceutical companies face stringent regulations from agencies like the FDA and EMA. Blockchain simplifies compliance by providing a transparent and auditable record of every transaction, from manufacturing to distribution, ensuring adherence to regulatory requirements.
4. Improved Drug Recall Management
In the event of a drug recall, blockchain enables rapid identification of affected batches and their distribution channels. This minimizes the impact on patients and reduces financial losses for manufacturers.
5. Enhanced Data Security and Privacy
Blockchain’s cryptographic algorithms ensure secure storage and sharing of sensitive data, such as patient records and clinical trial data. This is particularly important in an era of increasing cyber threats and data breaches.
This report aims to provide a comprehensive presentation of the global market for Blockchain In Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blockchain In Pharmaceutical by region & country, by Type, and by Application.
The Blockchain In Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blockchain In Pharmaceutical.
Market Segmentation
By Company
IBM
AWS
Microsoft
SAP
Chronicled
Embleema
FarmaTrust
Guardtime Federal
Segment by Type
Private Blockchain
Hybrid Blockchain
Segment by Application
Supply Chain Logistics
Drug Safety
Clinical Trial Management
IOMT & Cyber Security
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blockchain In Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blockchain In Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blockchain In Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Blockchain In Pharmaceutical Product Introduction
1.2 Global Blockchain In Pharmaceutical Market Size Forecast (2020-2031)
1.3 Blockchain In Pharmaceutical Market Trends & Drivers
1.3.1 Blockchain In Pharmaceutical Industry Trends
1.3.2 Blockchain In Pharmaceutical Market Drivers & Opportunity
1.3.3 Blockchain In Pharmaceutical Market Challenges
1.3.4 Blockchain In Pharmaceutical Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blockchain In Pharmaceutical Players Revenue Ranking (2024)
2.2 Global Blockchain In Pharmaceutical Revenue by Company (2020-2025)
2.3 Key Companies Blockchain In Pharmaceutical Manufacturing Base Distribution and Headquarters
2.4 Key Companies Blockchain In Pharmaceutical Product Offered
2.5 Key Companies Time to Begin Mass Production of Blockchain In Pharmaceutical
2.6 Blockchain In Pharmaceutical Market Competitive Analysis
2.6.1 Blockchain In Pharmaceutical Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Blockchain In Pharmaceutical Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blockchain In Pharmaceutical as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Private Blockchain
3.1.2 Hybrid Blockchain
3.2 Global Blockchain In Pharmaceutical Sales Value by Type
3.2.1 Global Blockchain In Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Blockchain In Pharmaceutical Sales Value, by Type (2020-2031)
3.2.3 Global Blockchain In Pharmaceutical Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Supply Chain Logistics
4.1.2 Drug Safety
4.1.3 Clinical Trial Management
4.1.4 IOMT & Cyber Security
4.2 Global Blockchain In Pharmaceutical Sales Value by Application
4.2.1 Global Blockchain In Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Blockchain In Pharmaceutical Sales Value, by Application (2020-2031)
4.2.3 Global Blockchain In Pharmaceutical Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Blockchain In Pharmaceutical Sales Value by Region
5.1.1 Global Blockchain In Pharmaceutical Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Blockchain In Pharmaceutical Sales Value by Region (2020-2025)
5.1.3 Global Blockchain In Pharmaceutical Sales Value by Region (2026-2031)
5.1.4 Global Blockchain In Pharmaceutical Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Blockchain In Pharmaceutical Sales Value, 2020-2031
5.2.2 North America Blockchain In Pharmaceutical Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Blockchain In Pharmaceutical Sales Value, 2020-2031
5.3.2 Europe Blockchain In Pharmaceutical Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Blockchain In Pharmaceutical Sales Value, 2020-2031
5.4.2 Asia Pacific Blockchain In Pharmaceutical Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Blockchain In Pharmaceutical Sales Value, 2020-2031
5.5.2 South America Blockchain In Pharmaceutical Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Blockchain In Pharmaceutical Sales Value, 2020-2031
5.6.2 Middle East & Africa Blockchain In Pharmaceutical Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blockchain In Pharmaceutical Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Blockchain In Pharmaceutical Sales Value, 2020-2031
6.3 United States
6.3.1 United States Blockchain In Pharmaceutical Sales Value, 2020-2031
6.3.2 United States Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Blockchain In Pharmaceutical Sales Value, 2020-2031
6.4.2 Europe Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Blockchain In Pharmaceutical Sales Value, 2020-2031
6.5.2 China Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.5.3 China Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Blockchain In Pharmaceutical Sales Value, 2020-2031
6.6.2 Japan Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Blockchain In Pharmaceutical Sales Value, 2020-2031
6.7.2 South Korea Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Blockchain In Pharmaceutical Sales Value, 2020-2031
6.8.2 Southeast Asia Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Blockchain In Pharmaceutical Sales Value, 2020-2031
6.9.2 India Blockchain In Pharmaceutical Sales Value by Type (%), 2024 VS 2031
6.9.3 India Blockchain In Pharmaceutical Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 IBM
7.1.1 IBM Profile
7.1.2 IBM Main Business
7.1.3 IBM Blockchain In Pharmaceutical Products, Services and Solutions
7.1.4 IBM Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.1.5 IBM Recent Developments
7.2 AWS
7.2.1 AWS Profile
7.2.2 AWS Main Business
7.2.3 AWS Blockchain In Pharmaceutical Products, Services and Solutions
7.2.4 AWS Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.2.5 AWS Recent Developments
7.3 Microsoft
7.3.1 Microsoft Profile
7.3.2 Microsoft Main Business
7.3.3 Microsoft Blockchain In Pharmaceutical Products, Services and Solutions
7.3.4 Microsoft Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.3.5 Microsoft Recent Developments
7.4 SAP
7.4.1 SAP Profile
7.4.2 SAP Main Business
7.4.3 SAP Blockchain In Pharmaceutical Products, Services and Solutions
7.4.4 SAP Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.4.5 SAP Recent Developments
7.5 Chronicled
7.5.1 Chronicled Profile
7.5.2 Chronicled Main Business
7.5.3 Chronicled Blockchain In Pharmaceutical Products, Services and Solutions
7.5.4 Chronicled Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.5.5 Chronicled Recent Developments
7.6 Embleema
7.6.1 Embleema Profile
7.6.2 Embleema Main Business
7.6.3 Embleema Blockchain In Pharmaceutical Products, Services and Solutions
7.6.4 Embleema Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.6.5 Embleema Recent Developments
7.7 FarmaTrust
7.7.1 FarmaTrust Profile
7.7.2 FarmaTrust Main Business
7.7.3 FarmaTrust Blockchain In Pharmaceutical Products, Services and Solutions
7.7.4 FarmaTrust Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.7.5 FarmaTrust Recent Developments
7.8 Guardtime Federal
7.8.1 Guardtime Federal Profile
7.8.2 Guardtime Federal Main Business
7.8.3 Guardtime Federal Blockchain In Pharmaceutical Products, Services and Solutions
7.8.4 Guardtime Federal Blockchain In Pharmaceutical Revenue (US$ Million) & (2020-2025)
7.8.5 Guardtime Federal Recent Developments
8 Industry Chain Analysis
8.1 Blockchain In Pharmaceutical Industrial Chain
8.2 Blockchain In Pharmaceutical Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blockchain In Pharmaceutical Sales Model
8.5.2 Sales Channel
8.5.3 Blockchain In Pharmaceutical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer